Details for 2016782161

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATION AUS EINEM BTK-INHIBITOR UND EINEM CHECKPOINT-INHIBITOR ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016782161

EP Publication Number

3355875

E-Number

1433593

Language

PCT Number

US16054731

Publication Date

08.08.2018 A

29.09.2021 B1

Registration Date

29.09.2021

AT Publication Date

15.10.2021

Application Date

30.09.2016

Registration Number

Priorities

01.10.2015

201562236064 P

17.12.2015

201562269007 P

IPC

A61K 31/122 20060101AFI20210304BHEP

Maximum Duration of Protection

30.09.2036

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

ONO Pharmaceutical Co., Ltd.1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526JP

Representative

No representatives present

Inventor

VENKATARAMAN, Sriramc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

TUMAS, Danielc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

TANAKA, Koheic/o Ono Pharmaceutical Co., Ltd. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585JP

YASUHIRO, Tomokoc/o Ono Pharmaceutical Co., Ltd. 1-1 Sakurai 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585JP

YOSHIZAWA, Toshioc/o Ono Pharmaceutical Co., Ltd. 1-1 Sakural 3-chome Shimamoto-cho Mishima-gun Osaka 618-8585JP